{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T19:59:47Z","timestamp":1762459187821},"reference-count":95,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2014,2,27]],"date-time":"2014-02-27T00:00:00Z","timestamp":1393459200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BioDrugs"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1007\/s40259-014-0087-0","type":"journal-article","created":{"date-parts":[[2014,2,26]],"date-time":"2014-02-26T14:12:16Z","timestamp":1393423936000},"page":"345-361","source":"Crossref","is-referenced-by-count":13,"title":["siRNA Technology in Kidney Transplantation: Current Status and Future Potential"],"prefix":"10.1007","volume":"28","author":[{"given":"Kristina","family":"Glebova","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oleg N.","family":"Reznik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander O.","family":"Reznik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rohini","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Galkin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ancha","family":"Baranova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mikhail","family":"Skoblov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,2,27]]},"reference":[{"key":"87_CR1","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1056\/NEJMra033540","volume":"351","author":"PF Halloran","year":"2004","unstructured":"Halloran PF. Immunosuppressive drugs for kidney transplantation. N Engl J Med. 2004;351:2715\u201329.","journal-title":"N Engl J Med"},{"key":"87_CR2","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1111\/j.1600-6143.2011.03445.x","volume":"11","author":"JE Murray","year":"2011","unstructured":"Murray JE. Ronald Lee Herrick Memorial: June 15, 1931\u2013December 27, 2010. Am J Transplant. 2011;11:419.","journal-title":"Am J Transplant"},{"key":"87_CR3","doi-asserted-by":"crossref","first-page":"3015","DOI":"10.1681\/ASN.2005050463","volume":"16","author":"JR Chapman","year":"2005","unstructured":"Chapman JR, O\u2019Connell PJ, Nankivell BJ. Chronic renal allograft dysfunction. J Am Soc Nephrol. 2005;16:3015\u201326.","journal-title":"J Am Soc Nephrol"},{"key":"87_CR4","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.trim.2006.10.001","volume":"16","author":"PJ Yates","year":"2006","unstructured":"Yates PJ, Nicholson ML. The aetiology and pathogenesis of chronic allograft nephropathy. Transpl Immunol. 2006;16:148\u201357.","journal-title":"Transpl Immunol"},{"key":"87_CR5","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1016\/j.addr.2010.07.010","volume":"62","author":"M Sandovici","year":"2010","unstructured":"Sandovici M, Deelman LE, Benigni A, Henning RH. Towards graft-specific immune suppression: gene therapy of the transplanted kidney. Adv Drug Deliv Rev. 2010;62:1358\u201368.","journal-title":"Adv Drug Deliv Rev"},{"key":"87_CR6","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1111\/j.1600-6143.2009.02713.x","volume":"9","author":"WN Nijboer","year":"2009","unstructured":"Nijboer WN, Schuurs TA, Damman J, et al. Kidney injury molecule-1 is an early noninvasive indicator for donor brain death-induced injury prior to kidney transplantation. Am J Transplant. 2009;9:1752\u20139.","journal-title":"Am J Transplant"},{"key":"87_CR7","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1097\/01.tp.0000262015.77625.90","volume":"83","author":"S Yilmaz","year":"2007","unstructured":"Yilmaz S, McLaughlin K, Paavonen T, et al. Clinical predictors of renal allograft histopathology: a comparative study of single-lesion histology versus a composite, quantitative scoring system. Transplantation. 2007;83:671\u20136.","journal-title":"Transplantation"},{"key":"87_CR8","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1093\/ndt\/gfn667","volume":"24","author":"SG Yarlagadda","year":"2009","unstructured":"Yarlagadda SG, Coca SG, Formica RN Jr, et al. Association between delayed graft function and allograft and patient survival: a systematic review and meta-analysis. Nephrol Dial Transplant. 2009;24:1039\u201347.","journal-title":"Nephrol Dial Transplant"},{"key":"87_CR9","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.2165\/11319260-000000000-00000","volume":"69","author":"R Marc\u00e9n","year":"2009","unstructured":"Marc\u00e9n R. Immunosuppressive drugs in kidney transplantation: impact on patient survival, and incidence of cardiovascular disease, malignancy and infection. Drugs. 2009;69:2227\u201343.","journal-title":"Drugs"},{"key":"87_CR10","first-page":"371","volume":"46","author":"KV Glebova","year":"2012","unstructured":"Glebova KV, Marakhonov AV, Baranova AV, Skoblov MIu. Therapeutic siRNAs and non-viral systems for their delivery. Mol Biol (Mosk). 2012;46:371\u201386.","journal-title":"Mol Biol (Mosk)"},{"key":"87_CR11","doi-asserted-by":"crossref","first-page":"4805","DOI":"10.1111\/j.1742-4658.2010.07902.x","volume":"277","author":"SP Walton","year":"2010","unstructured":"Walton SP. Engineering active siRNA therapeutics. FEBS J. 2010;277:4805.","journal-title":"FEBS J"},{"key":"87_CR12","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.ejphar.2008.02.087","volume":"585","author":"M Sandovici","year":"2008","unstructured":"Sandovici M, Deelman LE, de Zeeuw D, et al. Immune modulation and graft protection by gene therapy in kidney transplantation. Eur J Pharmacol. 2008;585:261\u20139.","journal-title":"Eur J Pharmacol"},{"key":"87_CR13","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1111\/j.1600-6143.2005.01228.x","volume":"6","author":"P Boros","year":"2006","unstructured":"Boros P, Bromberg JS. New cellular and molecular immune pathways in ischemia\/reperfusion injury. Am J Transplant. 2006;6:652\u20138.","journal-title":"Am J Transplant"},{"key":"87_CR14","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1097\/00007890-200011270-00005","volume":"70","author":"AK Salahudeen","year":"2000","unstructured":"Salahudeen AK, Huang H, Patel P, Jenkins JK. Mechanism and prevention of cold storage-induced human renal tubular cell injury. Transplantation. 2000;70:1424\u201331.","journal-title":"Transplantation"},{"key":"87_CR15","doi-asserted-by":"crossref","first-page":"3279","DOI":"10.1016\/j.transproceed.2008.10.004","volume":"40","author":"M Kosieradzki","year":"2008","unstructured":"Kosieradzki M, Rowi\u0144ski W. Ischemia\/reperfusion injury in kidney transplantation: mechanisms and prevention. Transplant Proc. 2008;40:3279\u201388.","journal-title":"Transplant Proc"},{"key":"87_CR16","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1146\/annurev.me.36.020185.001013","volume":"36","author":"KA Fox","year":"1985","unstructured":"Fox KA, Bergmann SR, Sobel BE. Pathophysiology of myocardial reperfusion. Annu Rev Med. 1985;36:125\u201344.","journal-title":"Annu Rev Med"},{"key":"87_CR17","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1146\/annurev.pharmtox.37.1.327","volume":"37","author":"JJ Lemasters","year":"1997","unstructured":"Lemasters JJ, Thurman RG. Reperfusion injury after liver preservation for transplantation. Annu Rev Pharmacol Toxicol. 1997;37:327\u201338.","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"87_CR18","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.semnephrol.2010.03.005","volume":"30","author":"L Li","year":"2010","unstructured":"Li L, Okusa MD. Macrophages, dendritic cells, and kidney ischemia\u2013reperfusion injury. Semin Nephrol. 2010;30:268\u201377.","journal-title":"Semin Nephrol"},{"key":"87_CR19","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1097\/00041552-200301000-00014","volume":"12","author":"MJ Burne-Taney","year":"2003","unstructured":"Burne-Taney MJ, Rabb H. The role of adhesion molecules and T cells in ischemic renal injury. Curr Opin Nephrol Hypertens. 2003;12:85\u201390.","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"87_CR20","doi-asserted-by":"crossref","first-page":"F87","DOI":"10.1152\/ajprenal.00026.2003","volume":"285","author":"MJ Burne-Taney","year":"2003","unstructured":"Burne-Taney MJ, Kofler J, Yokota N, Weisfeldt M, Traystman RJ, Rabb H. Acute renal failure after whole body ischemia is characterized by inflammation and T cell-mediated injury. Am J Physiol Renal Physiol. 2003;285:F87\u201394.","journal-title":"Am J Physiol Renal Physiol"},{"key":"87_CR21","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1111\/j.1523-1755.2005.67109.x","volume":"67","author":"JM Thurman","year":"2005","unstructured":"Thurman JM, Lucia MS, Ljubanovic D, Holers VM. Acute tubular necrosis is characterized by activation of the alternative pathway of complement. Kidney Int. 2005;67:524\u201330.","journal-title":"Kidney Int"},{"key":"87_CR22","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/S0002-9440(10)64596-8","volume":"157","author":"JR Pratt","year":"2000","unstructured":"Pratt JR, Abe K, Miyazaki M, Zhou W, Sacks SH. In situ localization of C3 synthesis in experimental acute renal allograft rejection. Am J Pathol. 2000;157:825\u201331.","journal-title":"Am J Pathol"},{"key":"87_CR23","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/978-1-4614-4118-2_17","volume":"735","author":"S Sacks","year":"2013","unstructured":"Sacks S, Karegli J, Farrar CA, Asgari E, Schwaeble W, Zhou W, Smith RA. Targeting complement at the time of transplantation. Adv Exp Med Biol. 2013;735:247\u201355.","journal-title":"Adv Exp Med Biol"},{"key":"87_CR24","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1681\/ASN.2008111145","volume":"20","author":"M Naesens","year":"2009","unstructured":"Naesens M, Li L, Ying L, Sansanwal P, Sigdel TK, Hsieh SC, Kambham N, Lerut E, Salvatierra O, Butte AJ, Sarwal MM. Expression of complement components differs between kidney allografts from living and deceased donors. J Am Soc Nephrol. 2009;20:1839\u201351.","journal-title":"J Am Soc Nephrol"},{"key":"87_CR25","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/j.1600-6143.2008.02519.x","volume":"9","author":"ZM El-Zoghby","year":"2009","unstructured":"El-Zoghby ZM, Stegall MD, Lager DJ, Kremers WK, Amer H, Gloor JM, Cosio FG. Identifying specific causes of kidney allograft loss. Am J Transplant. 2009;9:527\u201335.","journal-title":"Am J Transplant"},{"issue":"Suppl 15","key":"87_CR26","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1681\/ASN.V11suppl_1s1","volume":"11","author":"BL Kasiske","year":"2000","unstructured":"Kasiske BL, Vazquez MA, Harmon WE, Brown RS, Danovitch GM, Gaston RS, Roth D, Scandling JD, Singer GG. Recommendations for the outpatient surveillance of renal transplant recipients. American Society of Transplantation. J Am Soc Nephrol. 2000;11(Suppl 15):S1\u201386.","journal-title":"J Am Soc Nephrol"},{"key":"87_CR27","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1097\/MNH.0b013e32835903f4","volume":"21","author":"JR Chapman","year":"2012","unstructured":"Chapman JR. Do protocol transplant biopsies improve kidney transplant outcomes? Curr Opin Nephrol Hypertens. 2012;21:580\u20136.","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"87_CR28","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1016\/S0140-6736(04)17406-0","volume":"364","author":"N Perico","year":"2004","unstructured":"Perico N, Cattaneo D, Sayegh MH, Remuzzi G. Delayed graft function in kidney transplantation. Lancet. 2004;364:1814\u201327.","journal-title":"Lancet"},{"key":"87_CR29","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/j.1399-0012.2010.01241.x","volume":"25","author":"RP Singh","year":"2011","unstructured":"Singh RP, Farney AC, Rogers J, Zuckerman J, Reeves-Daniel A, Hartmann E, Iskandar S, Adams P, Stratta RJ. Kidney transplantation from donation after cardiac death donors: lack of impact of delayed graft function on post-transplant outcomes. Clin Transplant. 2011;25:255\u201364.","journal-title":"Clin Transplant"},{"key":"87_CR30","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1097\/MOT.0b013e32833593eb","volume":"15","author":"MG Snoeijs","year":"2010","unstructured":"Snoeijs MG, van Heurn LW, Buurman WA. Biological modulation of renal ischemia\u2013reperfusion injury. Curr Opin Organ Transplant. 2010;15:190\u20139.","journal-title":"Curr Opin Organ Transplant"},{"key":"87_CR31","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1681\/ASN.2007080913","volume":"19","author":"S Rosen","year":"2008","unstructured":"Rosen S, Stillman IE. Acute tubular necrosis is a syndrome of physiologic and pathologic dissociation. J Am Soc Nephrol. 2008;19:871\u20135.","journal-title":"J Am Soc Nephrol"},{"key":"87_CR32","first-page":"CD003421","volume":"17","author":"IR Shilliday","year":"2007","unstructured":"Shilliday IR, Sherif M. Calcium channel blockers for preventing acute tubular necrosis in kidney transplant recipients. Cochrane Database Syst Rev. 2007;17:CD003421.","journal-title":"Cochrane Database Syst Rev"},{"key":"87_CR33","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1038\/ki.2010.419","volume":"119","author":"LC Racusen","year":"2010","unstructured":"Racusen LC, Regele H. The pathology of chronic allograft dysfunction. Kidney Int Suppl. 2010;119:S27\u201332.","journal-title":"Kidney Int Suppl"},{"issue":"Suppl 21","key":"87_CR34","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/j.1399-0012.2009.01106.x","volume":"23","author":"F Strutz","year":"2009","unstructured":"Strutz F. Pathogenesis of tubulointerstitial fibrosis in chronic allograft dysfunction. Clin Transplant. 2009;23(Suppl 21):26\u201332.","journal-title":"Clin Transplant"},{"key":"87_CR35","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.5301\/jn.5000274","volume":"26","author":"AL Nogare","year":"2013","unstructured":"Nogare AL, Dalpiaz T, Pedroso JA, Montenegro RM, Pegas KL, Veronese FV, Gon\u00e7alves LF, Manfro RC. Expression of fibrosis-related genes in human renal allografts with interstitial fibrosis and tubular atrophy. J Nephrol. 2013;26:1179\u201387.","journal-title":"J Nephrol"},{"key":"87_CR36","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1038\/sj.ki.5000328","volume":"69","author":"P Pribylova-Hribova","year":"2006","unstructured":"Pribylova-Hribova P, Kotsch K, Lodererova A, Viklicky O, Vitko S, Volk HD, Lacha J. TGF-beta1 mRNA upregulation influences chronic renal allograft dysfunction. Kidney Int. 2006;69:1872\u20139.","journal-title":"Kidney Int"},{"key":"87_CR37","doi-asserted-by":"crossref","first-page":"F199","DOI":"10.1152\/ajprenal.00665.2012","volume":"305","author":"Q Guan","year":"2013","unstructured":"Guan Q, Li S, Gao S, Chen H, Nguan CY, Du C. Reduction of chronic rejection of renal allografts by anti-transforming growth factor-\u03b2 antibody therapy in a rat model. Am J Physiol Renal Physiol. 2013;305:F199\u2013207.","journal-title":"Am J Physiol Renal Physiol"},{"issue":"3","key":"87_CR38","first-page":"686","volume":"27","author":"M Yanagita","year":"2012","unstructured":"Yanagita M. Inhibitors\/antagonists of TGF-\u03b2 system in kidney fibrosis. Nephrol Dial Transplant. 2012;27(3):686\u201391.","journal-title":"Nephrol Dial Transplant"},{"key":"87_CR39","first-page":"655","volume":"124","author":"ZK Yin","year":"2011","unstructured":"Yin ZK, Wu XH, Xia YG, Luo CL. Transforming growth factor-\u03b21 short hairpin RNA inhibits renal allograft fibrosis. Chin Med J (Engl). 2011;124:655\u201363.","journal-title":"Chin Med J (Engl)"},{"key":"87_CR40","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.yexmp.2005.11.005","volume":"81","author":"M Hwang","year":"2006","unstructured":"Hwang M, Kim HJ, Noh HJ, Chang YC, Chae YM, Kim KH, Jeon JP, Lee TS, Oh HK, Lee YS, Park KK. TGF-beta1 siRNA suppresses the tubulointerstitial fibrosis in the kidney of ureteral obstruction. Exp Mol Pathol. 2006;81:48\u201354.","journal-title":"Exp Mol Pathol"},{"key":"87_CR41","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.jss.2012.07.015","volume":"181","author":"C Yang","year":"2013","unstructured":"Yang C, Jia Y, Zhao T, et al. Naked caspase\u00a03 small interfering RNA is effective in cold preservation but not in autotransplantation of porcine kidneys. J Surg Res. 2013;181:342\u201354.","journal-title":"J Surg Res"},{"key":"87_CR42","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1038\/gt.2011.39","volume":"18","author":"E Ripoll","year":"2011","unstructured":"Ripoll E, Pluvinet R, Torras J, Olivar R, Vidal A, Franquesa M, Cassis L, Cruzado JM, Bestard O, Griny\u00f3 JM, Aran JM, Herrero-Fresneda I. In vivo therapeutic efficacy of intra-renal CD40 silencing in a model of humoral acute rejection. Gene Ther. 2011;18:945\u201352.","journal-title":"Gene Ther"},{"key":"87_CR43","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1097\/MOT.0b013e3283446a43","volume":"16","author":"J Wind","year":"2011","unstructured":"Wind J, Hoogland ER, van Heurn LW. Preservation techniques for donors after cardiac death kidneys. Curr Opin Organ Transplant. 2011;16:157\u201361.","journal-title":"Curr Opin Organ Transplant"},{"key":"87_CR44","doi-asserted-by":"crossref","first-page":"14883","DOI":"10.1073\/pnas.0406421101","volume":"101","author":"P Hamar","year":"2004","unstructured":"Hamar P, Song E, K\u00f6k\u00e9ny G, et al. Small interfering RNA targeting Fas protects mice from renal ischemia\u2013reperfusion injury. Proc Natl Acad Sci USA. 2004;101:14883\u20138.","journal-title":"Proc Natl Acad Sci USA"},{"key":"87_CR45","doi-asserted-by":"crossref","first-page":"F857","DOI":"10.1152\/ajprenal.00547.2010","volume":"300","author":"X Wan","year":"2011","unstructured":"Wan X, Fan L, Hu B, Yang J, Li X, Chen X, Cao C. Small interfering RNA targeting IKK\u03b2 prevents renal ischemia\u2013reperfusion injury in rats. Am J Physiol Renal Physiol. 2011;300:F857\u201363.","journal-title":"Am J Physiol Renal Physiol"},{"key":"87_CR46","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.3727\/096368910X516619","volume":"19","author":"R Imamura","year":"2010","unstructured":"Imamura R, Isaka Y, Sandoval RM, et al. Intravital two-photon microscopy assessment of renal protection efficacy of siRNA for p53 in experimental rat kidney transplantation models. Cell Transplant. 2010;19:1659\u201370.","journal-title":"Cell Transplant"},{"key":"87_CR47","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1097\/TP.0b013e318207949f","volume":"91","author":"B Yang","year":"2011","unstructured":"Yang B, Hosgood SA, Nicholson ML. Naked small interfering RNA of caspase-3 in preservation solution and autologous blood perfusate protects isolated ischemic porcine kidneys. Transplantation. 2011;91:501\u20137.","journal-title":"Transplantation"},{"key":"87_CR48","author":"PT Murray","year":"2013","unstructured":"Murray PT, Mehta RL, Shaw A, Ronco C, Endre Z, Kellum JA, Chawla LS, Cruz D, Ince C, Okusa MD. Current use of biomarkers in acute kidney injury: report and summary of recommendations from the 10th Acute Dialysis Quality Initiative consensus conference. Kidney Int. 2013. doi: 10.1038\/ki.2013.374","journal-title":"Kidney Int"},{"key":"87_CR49","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1681\/ASN.2008111204","volume":"20","author":"BA Molitoris","year":"2009","unstructured":"Molitoris BA, Dagher PC, Sandoval RM, Campos SB, Ashush H, Fridman E, Brafman A, Faerman A, Atkinson SJ, Thompson JD, Kalinski H, Skaliter R, Erlich S, Feinstein E. siRNA targeted to p53 attenuates ischemic and cisplatin-induced acute kidney injury. J Am Soc Nephrol. 2009;20:1754\u201364.","journal-title":"J Am Soc Nephrol"},{"key":"87_CR50","doi-asserted-by":"crossref","first-page":"2997","DOI":"10.1097\/CCM.0b013e31825b912d","volume":"40","author":"SY Lee","year":"2012","unstructured":"Lee SY, Lee YS, Choi HM, Ko YS, Lee HY, Jo SK, Cho WY, Kim HK. Distinct pathophysiologic mechanisms of septic acute kidney injury: role of immune suppression and renal tubular cell apoptosis in murine model of septic acute kidney injury. Crit Care Med. 2012;40:2997\u20133006.","journal-title":"Crit Care Med"},{"key":"87_CR51","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1053\/j.ajkd.2012.10.026","volume":"62","author":"S Husain","year":"2013","unstructured":"Husain S, Sis B. Advances in the understanding of transplant glomerulopathy. Am J Kidney Dis. 2013;62:352\u201363.","journal-title":"Am J Kidney Dis"},{"issue":"Suppl 2","key":"87_CR52","doi-asserted-by":"crossref","first-page":"S56","DOI":"10.2215\/CJN.03040707","volume":"3","author":"AM Jevnikar","year":"2008","unstructured":"Jevnikar AM, Mannon RB. Late kidney allograft loss: what we know about it, and what we can do about it. Clin J Am Soc Nephrol. 2008;3(Suppl 2):S56\u201367.","journal-title":"Clin J Am Soc Nephrol"},{"key":"87_CR53","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1016\/j.transproceed.2008.07.100","volume":"40","author":"GH Luo","year":"2008","unstructured":"Luo GH, Lu YP, Song J, Yang L, Shi YJ, Li YP. Inhibition of connective tissue growth factor by small interfering RNA prevents renal fibrosis in rats undergoing chronic allograft nephropathy. Transplant Proc. 2008;40:2365\u20139.","journal-title":"Transplant Proc"},{"key":"87_CR54","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1046\/j.1523-1755.2002.00164.x","volume":"61","author":"Q Al Awqati","year":"2002","unstructured":"Al Awqati Q, Oliver JA. Stem cells in the kidney. Kidney Int. 2002;61:387\u201395.","journal-title":"Kidney Int"},{"key":"87_CR55","first-page":"S2","volume":"30","author":"W Kriz","year":"1990","unstructured":"Kriz W, Elger M, Lemley K, Sakai T. Structure of the glomerular mesangium: a biomechanical interpretation. Kidney Int Suppl. 1990;30:S2\u20139.","journal-title":"Kidney Int Suppl"},{"key":"87_CR56","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s10157-006-0442-7","volume":"10","author":"Y Isaka","year":"2006","unstructured":"Isaka Y. Gene therapy targeting kidney diseases: routes and vehicles. Clin Exp Nephrol. 2006;10:229\u201335.","journal-title":"Clin Exp Nephrol"},{"key":"87_CR57","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1007\/s00467-011-1992-9","volume":"27","author":"KS Hodgkins","year":"2012","unstructured":"Hodgkins KS, Schnaper HW. Tubulointerstitial injury and the progression of chronic kidney disease. Pediatr Nephrol. 2012;27:901\u20139.","journal-title":"Pediatr Nephrol"},{"key":"87_CR58","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1476-9255-7-19","volume":"7","author":"MT Grande","year":"2010","unstructured":"Grande MT, P\u00e9rez-Barriocanal F, L\u00f3pez-Novoa JM. Role of inflammation in tubulo-interstitial damage associated to obstructive nephropathy. J Inflamm (Lond). 2010;7:19.","journal-title":"J Inflamm (Lond)"},{"key":"87_CR59","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.jconrel.2005.11.007","volume":"110","author":"T Kushibiki","year":"2006","unstructured":"Kushibiki T, Nagata-Nakajima N, Sugai M, et al. Enhanced anti-fibrotic activity of plasmid DNA expressing small interference RNA for TGF-beta type\u00a0II receptor for a mouse model of obstructive nephropathy by cationized gelatin prepared from different amine compounds. J Control Release. 2006;110:610\u20137.","journal-title":"J Control Release"},{"key":"87_CR60","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1124\/dmd.106.009555","volume":"34","author":"FM van de Water","year":"2006","unstructured":"van de Water FM, Boerman OC, Wouterse AC, et al. Intravenously administered short interfering RNA accumulates in the kidney and selectively suppresses gene function in renal proximal tubules. Drug Metab Dispos. 2006;34:1393\u20137.","journal-title":"Drug Metab Dispos"},{"key":"87_CR61","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1089\/nat.2012.0371","volume":"22","author":"JD Thompson","year":"2012","unstructured":"Thompson JD, Kornbrust DJ, Foy JW, et al. Toxicological and pharmacokinetic properties of chemically modified siRNAs targeting p53 RNA following intravenous administration. Nucleic Acid Ther. 2012;22:255\u201364.","journal-title":"Nucleic Acid Ther"},{"key":"87_CR62","first-page":"387","volume":"46","author":"KV Glebova","year":"2012","unstructured":"Glebova KV, Marakhonov AV, Baranova AV, Skoblov MIu. Types of non-viral delivery systems of small interfering RNA. Mol Biol (Mosk). 2012;46:387\u2013401.","journal-title":"Mol Biol (Mosk)"},{"key":"87_CR63","doi-asserted-by":"crossref","first-page":"197","DOI":"10.2174\/092986712803414141","volume":"19","author":"M Jafari","year":"2012","unstructured":"Jafari M, Soltani M, Naahidi S, et al. Nonviral approach for targeted nucleic acid delivery. Curr Med Chem. 2012;19:197\u2013208.","journal-title":"Curr Med Chem"},{"key":"87_CR64","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.bbrc.2007.08.189","volume":"363","author":"Y Takabatake","year":"2007","unstructured":"Takabatake Y, Isaka Y, Mizui M, et al. Chemically modified siRNA prolonged RNA interference in renal disease. Biochem Biophys Res Commun. 2007;363:432\u20137.","journal-title":"Biochem Biophys Res Commun"},{"key":"87_CR65","doi-asserted-by":"crossref","first-page":"F196","DOI":"10.1152\/ajprenal.90607.2008","volume":"298","author":"K H\u00f6cherl","year":"2010","unstructured":"H\u00f6cherl K, Schmidt C, Kurt B, Bucher M. Inhibition of NF-kappaB ameliorates sepsis-induced downregulation of aquaporin-2\/V2 receptor expression and acute renal failure in vivo. Am J Physiol Renal Physiol. 2010;298:F196\u2013204.","journal-title":"Am J Physiol Renal Physiol"},{"key":"87_CR66","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1002\/biot.201100054","volume":"6","author":"JC Burnett","year":"2011","unstructured":"Burnett JC, Rossi JJ, Tiemann K. Current progress of siRNA\/shRNA therapeutics in clinical trials. Biotechnol J. 2011;6:1130\u201346.","journal-title":"Biotechnol J"},{"key":"87_CR67","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/nbt0502-446","volume":"20","author":"T Tuschl","year":"2002","unstructured":"Tuschl T. Expanding small RNA interference. Nat Biotechnol. 2002;20:446\u20138.","journal-title":"Nat Biotechnol"},{"key":"87_CR68","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/j.addr.2009.04.006","volume":"61","author":"Y Takahashi","year":"2009","unstructured":"Takahashi Y, Nishikawa M, Takakura Y. Nonviral vector-mediated RNA interference: its gene silencing characteristics and important factors to achieve RNAi-based gene therapy. Adv Drug Deliv Rev. 2009;61:760\u20136.","journal-title":"Adv Drug Deliv Rev"},{"key":"87_CR69","doi-asserted-by":"crossref","first-page":"89","DOI":"10.2174\/1566523044578077","volume":"4","author":"ED Papadakis","year":"2004","unstructured":"Papadakis ED, Nicklin SA, Baker AH, White SJ. Promoters and control elements: designing expression cassettes for gene therapy. Curr Gene Ther. 2004;4:89\u2013113.","journal-title":"Curr Gene Ther"},{"key":"87_CR70","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1038\/sj.gt.3302480","volume":"12","author":"Y Takabatake","year":"2005","unstructured":"Takabatake Y, Isaka Y, Mizui M, et al. Exploring RNA interference as a therapeutic strategy for renal disease. Gene Ther. 2005;12:965\u201373.","journal-title":"Gene Ther"},{"key":"87_CR71","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/978-1-59745-352-3_18","volume":"466","author":"Y Takabatake","year":"2009","unstructured":"Takabatake Y, Isaka Y, Imai E. In vivo transfer of small interfering RNA or small hairpin RNA targeting glomeruli. Methods Mol Biol. 2009;466:251\u201363.","journal-title":"Methods Mol Biol"},{"key":"87_CR72","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.jconrel.2005.02.030","volume":"105","author":"T Kushibiki","year":"2005","unstructured":"Kushibiki T, Nagata-Nakajima N, Sugai M, et al. Delivery of plasmid DNA expressing small interference RNA for TGF-beta type II receptor by cationized gelatin to prevent interstitial renal fibrosis. J Control Release. 2005;105:318\u201331.","journal-title":"J Control Release"},{"key":"87_CR73","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1111\/j.1600-6143.2006.01478.x","volume":"6","author":"C Du","year":"2006","unstructured":"Du C, Wang S, Diao H, et al. Increasing resistance of tubular epithelial cells to apoptosis by shRNA therapy ameliorates renal ischemia\u2013reperfusion injury. Am J Transplant. 2006;6:2256\u201367.","journal-title":"Am J Transplant"},{"key":"87_CR74","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.trre.2011.03.001","volume":"26","author":"ZX Zhang","year":"2012","unstructured":"Zhang ZX, Min WP, Jevnikar AM. Use of RNA interference to minimize ischemia reperfusion injury. Transplant Rev (Orlando). 2012;26:140\u201355.","journal-title":"Transplant Rev (Orlando)"},{"key":"87_CR75","doi-asserted-by":"crossref","first-page":"334","DOI":"10.3109\/0886022X.2011.559679","volume":"33","author":"C Zhou","year":"2011","unstructured":"Zhou C, Shan Y, Zhao H, He P. Biological effects of lentivirus-mediated shRNA targeting collagen type\u00a0I on the mesangial cells of rats. Ren Fail. 2011;33:334\u201340.","journal-title":"Ren Fail"},{"key":"87_CR76","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1177\/147323000903700320","volume":"37","author":"Z Shou","year":"2009","unstructured":"Shou Z, Xiao H, Xu Y, et al. SHARP-2 gene silencing by lentiviral-based short hairpin RNA interference prolonged rat kidney transplant recipients\u2019 survival time. J Int Med Res. 2009;37:766\u201378.","journal-title":"J Int Med Res"},{"key":"87_CR77","doi-asserted-by":"crossref","first-page":"5627","DOI":"10.1128\/JVI.00014-10","volume":"84","author":"K Breckpot","year":"2010","unstructured":"Breckpot K, Escors D, Arce F, et al. HIV-1 lentiviral vector immunogenicity is mediated by Toll-like receptor 3 (TLR3) and TLR7. J Virol. 2010;84:5627\u201336.","journal-title":"J Virol"},{"key":"87_CR78","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1681\/ASN.2009030295","volume":"21","author":"H Shimizu","year":"2010","unstructured":"Shimizu H, Hori Y, Kaname S, et al. siRNA-based therapy ameliorates glomerulonephritis. J Am Soc Nephrol. 2010;21:622\u201333.","journal-title":"J Am Soc Nephrol"},{"issue":"10","key":"87_CR79","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.3109\/0886022X.2012.723662","volume":"34","author":"L Li","year":"2012","unstructured":"Li L, Wu Y, Wang C, Zhang W. Inhibition of PAX2 gene expression by siRNA (polyethylenimine) in experimental model of obstructive nephropathy. Ren Fail. 2012;34(10):1288\u201396.","journal-title":"Ren Fail"},{"key":"87_CR80","doi-asserted-by":"crossref","first-page":"e9463","DOI":"10.1371\/journal.pone.0009463","volume":"5","author":"PV Hauser","year":"2010","unstructured":"Hauser PV, Pippin JW, Kaiser C, et al. Novel siRNA delivery system to target podocytes in vivo. PLoS ONE. 2010;5:e9463.","journal-title":"PLoS ONE"},{"issue":"176C","key":"87_CR81","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jconrel.2013.12.029","volume":"3","author":"PS Kowalski","year":"2014","unstructured":"Kowalski PS, Zwiers PJ, Morselt HW, Kuldo JM, Leus NG, Ruiters MH, Molema G, Kamps JA. Anti-VCAM-1 SAINT-O-Somes enable endothelial-specific delivery of siRNA and downregulation of inflammatory genes in activated endothelium in vivo. J Control Release. 2014;3(176C):64\u201375.","journal-title":"J Control Release"},{"key":"87_CR82","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1016\/j.biomaterials.2012.11.058","volume":"34","author":"B Naeye","year":"2013","unstructured":"Naeye B, Deschout H, Caveliers V, et al. In vivo disassembly of IV administered siRNA matrix nanoparticles at the renal filtration barrier. Biomaterials. 2013;34:2350\u20138.","journal-title":"Biomaterials"},{"key":"87_CR83","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1016\/j.addr.2010.07.005","volume":"62","author":"G Stokman","year":"2010","unstructured":"Stokman G, Qin Y, R\u00e1cz Z, et al. Application of siRNA in targeting protein expression in kidney disease. Adv Drug Deliv Rev. 2010;62:1378\u201389.","journal-title":"Adv Drug Deliv Rev"},{"key":"87_CR84","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.addr.2007.03.002","volume":"59","author":"DL Lewis","year":"2007","unstructured":"Lewis DL, Wolff JA. Systemic siRNA delivery via hydrodynamic intravascular injection. Adv Drug Deliv Rev. 2007;59:115\u201323.","journal-title":"Adv Drug Deliv Rev"},{"key":"87_CR85","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1517\/14712598.8.11.1645","volume":"8","author":"P Chiarella","year":"2008","unstructured":"Chiarella P, Massi E, De Robertis MA, et al. Electroporation of skeletal muscle induces danger signal release and antigen presenting cell recruitment independently of DNA vaccine administration. Expert Opin Biol Ther. 2008;8:1645\u201357.","journal-title":"Expert Opin Biol Ther"},{"key":"87_CR86","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.bbrc.2005.07.101","volume":"335","author":"M Kinoshita","year":"2005","unstructured":"Kinoshita M, Hynynen K. A novel method for the intracellular delivery of siRNA using microbubble-enhanced focused ultrasound. Biochem Biophys Res Commun. 2005;335:393\u20139.","journal-title":"Biochem Biophys Res Commun"},{"key":"87_CR87","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1002\/wsbm.134","volume":"3","author":"F Emmert-Streib","year":"2011","unstructured":"Emmert-Streib F, Glazko GV. Network biology: a direct approach to study biological function. Wiley Interdiscip Rev Syst Biol Med. 2011;3:379\u201391.","journal-title":"Wiley Interdiscip Rev Syst Biol Med"},{"issue":"9","key":"87_CR88","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1097\/TP.0b013e3181a1905e","volume":"87","author":"B Feng","year":"2009","unstructured":"Feng B, Chen G, Zheng X, et al. Small interfering RNA targeting RelB protects against renal ischemia\u2013reperfusion injury. Transplantation. 2009;87(9):1283\u20139.","journal-title":"Transplantation"},{"issue":"12","key":"87_CR89","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1097\/01.tp.0000250764.17636.ba","volume":"82","author":"X Zhang","year":"2006","unstructured":"Zhang X, Zheng X, Sun H, et al. Prevention of renal ischemic injury by silencing the expression of renal caspase\u00a03 and caspase\u00a08. Transplantation. 2006;82(12):1728\u201332.","journal-title":"Transplantation"},{"issue":"12","key":"87_CR90","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1097\/01.tp.0000250769.86623.a3","volume":"82","author":"X Zheng","year":"2006","unstructured":"Zheng X, Zhang X, Sun H, et al. Protection of renal ischemia injury using combination gene silencing of complement\u00a03 and caspase\u00a03 genes. Transplantation. 2006;82(12):1781\u20136.","journal-title":"Transplantation"},{"issue":"9","key":"87_CR91","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1111\/j.1600-6143.2006.01427.x","volume":"6","author":"X Zheng","year":"2006","unstructured":"Zheng X, Feng B, Chen G, et al. Preventing renal ischemia\u2013reperfusion injury using small interfering RNA by targeting complement\u00a03 gene. Am J Transplant. 2006;6(9):2099\u2013108.","journal-title":"Am J Transplant"},{"issue":"4","key":"87_CR92","doi-asserted-by":"crossref","first-page":"973","DOI":"10.2353\/ajpath.2008.080103","volume":"173","author":"X Zheng","year":"2008","unstructured":"Zheng X, Zhang X, Feng B, et al. Gene silencing of complement C5a receptor using siRNA for preventing ischemia\/reperfusion injury. Am J Pathol. 2008;173(4):973\u201380.","journal-title":"Am J Pathol"},{"issue":"2","key":"87_CR93","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1681\/ASN.2011050503","volume":"23","author":"SW Park","year":"2012","unstructured":"Park SW, Kim M, Brown KM, et al. Inhibition of sphingosine 1-phosphate receptor\u00a02 protects against renal ischemia\u2013reperfusion injury. J Am Soc Nephrol. 2012;23(2):266\u201380.","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"87_CR94","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1097\/TP.0b013e318207949f","volume":"91","author":"B Yang","year":"2011","unstructured":"Yang B, Hosgood SA, Nicholson ML. Naked small interfering RNA of caspase-3 in preservation solution and autologous blood perfusate protects isolated ischemic porcine kidneys. Transplantation. 2011;91(5):501\u20137.","journal-title":"Transplantation"},{"issue":"2","key":"87_CR95","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.jss.2012.07.015","volume":"181","author":"C Yang","year":"2013","unstructured":"Yang C, Jia Y, Zhao T, et al. Naked caspase\u00a03 small interfering RNA is effective in cold preservation but not in autotransplantation of porcine kidneys. J Surg Res. 2013;181(2):342\u201354.","journal-title":"J Surg Res"}],"container-title":["BioDrugs"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40259-014-0087-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40259-014-0087-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40259-014-0087-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,27]],"date-time":"2022-03-27T20:23:04Z","timestamp":1648412584000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40259-014-0087-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2,27]]},"references-count":95,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["87"],"URL":"https:\/\/doi.org\/10.1007\/s40259-014-0087-0","relation":{},"ISSN":["1173-8804","1179-190X"],"issn-type":[{"value":"1173-8804","type":"print"},{"value":"1179-190X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,2,27]]}}}